Cargando…

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

BACKGROUND: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. METHODS: In this controlled, open-label trial comparing a range of possible treatmen...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383595/ https://www.ncbi.nlm.nih.gov/pubmed/32678530 http://dx.doi.org/10.1056/NEJMoa2021436

Ejemplares similares

Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States
por: Choong, Casey Kar-Chan, et al.
Publicado: (2022)

Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
por: Calzetta, Luigino, et al.
Publicado: (2021)

Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
por: Sharun, Khan, et al.
Publicado: (2020)

Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia
por: Isaka, Yuri, et al.
Publicado: (2022)

WHO WELCOMES PRELIMINARY RESULTS ABOUT DEXAMETHASONE USE IN TREATING CRITICALLY ILL COVID -19 PATIENTS
Publicado: (2020)

Dexamethasone: COVID-19-pneumonia: case report
Publicado: (2022)

Assessment of the Effectiveness of a Protocol to Manage Dexamethasone-Induced Hyperglycemia Among Hospitalized Patients With COVID-19
por: Asiri, Alanood A., et al.
Publicado: (2021)

Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality
por: Huang, Cheng-Wei, et al.
Publicado: (2022)

The Effect of the Timing of Dexamethasone Administration in Patients with COVID-19 Pneumonia
por: Lee, Hyun Woo, et al.
Publicado: (2021)

Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone
por: Potere, Nicola, et al.
Publicado: (2021)

Bortezomib/dexamethasone: Covid-19 pneumonia: case report
Publicado: (2021)

Bortezomib/dexamethasone: COVID-19 infection: case report
Publicado: (2021)

Dexamethasone: Rebound of COVID-19-pneumonia: case report
Publicado: (2021)

THE EFFICACY OF REMDESIVIR WITH DEXAMETHASONE VS. DEXAMETHASONE ALONE IN ADULTS HOSPITALIZED WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study
por: Gressens, Simon B., et al.
Publicado: (2022)

Hospital at Home for Elderly COVID-19 Patients: A Preliminary Report with 100 Patients
por: Miyamoto, Yuki, et al.
Publicado: (2022)

Remdesivir plus dexamethasone is associated to improve the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status
por: Bernal, Enrique, et al.
Publicado: (2023)

Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support
por: Crothers, Kristina, et al.
Publicado: (2022)

Dexamethasone/temozolomide: COVID-19 and COVID-19 pneumonia: 5 case reports
Publicado: (2021)

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis
por: Pérez-Alba, Eduardo, et al.
Publicado: (2021)

Efficacy and Safety Comparison of Two Different Doses of Dexamethasone in Hospitalized Patients with COVID-19: A Randomized Clinical Trial
por: Sadeghi, Somayeh, et al.
Publicado: (2023)

Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital
por: Kumari, Abha, et al.
Publicado: (2021)

COVID-19, myocardial edema and dexamethasone
por: Rafiee, Moezedin Javad, et al.
Publicado: (2020)

Caution with the use of dexamethasone in patients with COVID-19 in its initial phases()
por: Callejas Rubio, J.L., et al.
Publicado: (2021)

Real-World Effectiveness of Nirmatrelvir/Ritonavir and Dexamethasone Among Hospitalized Patients with COVID-19: A Prospective Cohort Study
por: Liu, Wei, et al.
Publicado: (2023)

Dexamethasone for Inpatients With COVID-19 in a National Cohort
por: Mourad, Ahmad, et al.
Publicado: (2023)

Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease
por: Qutob, Haitham M.H., et al.
Publicado: (2022)

Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease
por: Qutob, Haitham M.H., et al.
Publicado: (2022)

Dexamethasone exposure in normal‐weight and obese hospitalized COVID‐19 patients: An observational exploratory trial
por: Abouir, Kenza, et al.
Publicado: (2022)

Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study
por: Kim, Won-Young, et al.
Publicado: (2021)

Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report
por: Corrao, Salvatore, et al.
Publicado: (2021)

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
por: Camon, Ana M., et al.
Publicado: (2022)

Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
por: Matthay, Michael A, et al.
Publicado: (2020)

Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
por: Perner, Anders, et al.
Publicado: (2023)

The use of dexamethasone in the treatment of COVID-19
por: Lester, Mohammed, et al.
Publicado: (2020)

Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study
por: Stanevich, O. V., et al.
Publicado: (2021)

The Effect of Dexamethasone Treatment on COVID-19 Prognosis in Cancer Patients
por: Souan, Lina, et al.
Publicado: (2022)

Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
por: Izumo, Takehiro, et al.
Publicado: (2021)

334. Impact of Overall Dexamethasone Exposure on Development of Invasive Pulmonary Aspergillosis in Hospitalized Patients with COVID-19
por: Skoglund, Erik, et al.
Publicado: (2021)

Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial()
por: Dastenae, Zahra Habibi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5r77h5d7bihk8r0g8p3mrimavv